tirzepatide pediatrics adolescent obesity trial Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, Tirzepatide as a Potential Disease-Modifying
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26


























